Line 135: | Line 135: | ||
<a href="https://2017.igem.org/Team:Paris_Bettencourt/RNA"><img class="logosubpinerte" src="https://static.igem.org/mediawiki/2017/1/17/GifRNAinertePB.png"><img class="logosubp" src="https://static.igem.org/mediawiki/2017/5/53/GifRNAPB.gif"></div></div></a> | <a href="https://2017.igem.org/Team:Paris_Bettencourt/RNA"><img class="logosubpinerte" src="https://static.igem.org/mediawiki/2017/1/17/GifRNAinertePB.png"><img class="logosubp" src="https://static.igem.org/mediawiki/2017/5/53/GifRNAPB.gif"></div></div></a> | ||
<div id="project4"><div class="logo"> | <div id="project4"><div class="logo"> | ||
− | <img class="logosubpinerte" src=""><img class="logosubp" src="">a</div></div> | + | <img class="logosubpinerte" src="https://static.igem.org/mediawiki/2017/c/c5/GifdrompainertePB.png"><img class="logosubp" src="https://static.igem.org/mediawiki/2017/e/e7/GifdrompaPB.gif">a</div></div> |
</div> | </div> | ||
</div> | </div> |
Revision as of 14:11, 1 November 2017
BRINGING CONTROL TO THETHIRD DIMENSION
Proof of concept - 3D printer:
by creating a printer, it is a clear and easily quantified way to validate our 3D controls.
It also allowed us to engineer biomaterials that would be compatible and useful in
biotech. We also optimised production by creating local concnetrations of enzymes in
the RNA organelles.